David Southwell

David Southwell

Company: TScan Therapeutics

Job title: President, CEO


Discovering TCRs Through Physical Reporters 10:00 am

T-cell targets of recovering COVID-19 patients were first discovered using a high-throughput, whole-genome reporter system Discovery of epitope targets in solid tumors is a major limitation for immunotherapy TScan’s system has discovered over 40 novel, shared cancer targets to date in solid tumorsRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.